The biotech firm Capricor Therapeutics (NASDAQ:CAPR) was on the radars of many investors yesterday and the company’s stock ended the day with gains of 5.5%. The gains made by the Capricor stock were reasonable but it is also true that there has been no new development about the company in recent weeks. In this situation, …
Continue reading “Capricor Therapeutics (NASDAQ:CAPR) Stock Bounces Back After The Fall: What Next?”